Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-24 @ 3:34 PM
Last Modification Date: 2025-12-24 @ 3:34 PM
Retention: SAMPLES_WITHOUT_DNA
Description: Biomarker analysis will be focused on measuring the levels of neurofilament light chain (NfL) in serum and/or plasma, which is one of the most promising blood biomarkers in MSA.

Analysis of CSF may include but is not limited to the following biomarkers: total alpha synuclein, aggregated alpha synuclein Tau/phosphorylated Tau, neurofilament light chain, neurofilament heavy chain, and catecholamines (dopamine, norepinephrine, DOPAC, DHPG).
Section: Biomarker analysis will be focused on measuring the levels of neurofilament light chain (NfL) in serum and/or plasma, which is one of the most promising blood biomarkers in MSA. Analysis of CSF may include but is not limited to the following biomarkers: total alpha synuclein, aggregated alpha synuclein Tau/phosphorylated Tau, neurofilament light chain, neurofilament heavy chain, and catecholamines (dopamine, norepinephrine, DOPAC, DHPG).